Ono Pharmaceutical Co (Ono Pharmaceutical Co) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Ono Pharmaceutical Co Dividend Payout Ratio?

Ono Pharmaceutical Co's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Ono Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:

OPHLY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.29 Med: 0.4 Max: 7.35
Current: 0.29

During the past 13 years, the highest Dividend Payout Ratio of Ono Pharmaceutical Co was 7.35. The lowest was 0.29. And the median was 0.40.

OPHLY's Dividend Payout Ratio is ranked better than
59.35% of 428 companies
in the Drug Manufacturers industry
Industry Median: 0.33 vs OPHLY: 0.29

As of today (2024-04-28), the Dividend Yield % of Ono Pharmaceutical Co is 3.63%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Ono Pharmaceutical Co was 3.63%. The lowest was 0.69%. And the median was 1.73%.

Ono Pharmaceutical Co's Dividends per Share for the months ended in Dec. 2023 was $0.00.

During the past 12 months, Ono Pharmaceutical Co's average Dividends Per Share Growth Rate was 26.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 15.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 5.90% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Ono Pharmaceutical Co was 44.20% per year. The lowest was 3.60% per year. And the median was 5.80% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Ono Pharmaceutical Co Dividend Payout Ratio Historical Data

The historical data trend for Ono Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Dividend Payout Ratio Chart

Ono Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.46

0.38

0.33

0.30

Ono Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	0.99	-	0.46	-

Competitive Comparison of Ono Pharmaceutical Co's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ono Pharmaceutical Co's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Dividend Payout Ratio falls into.

Ono Pharmaceutical Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Ono Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Mar. 2023 )	/	EPS without NRI (A: Mar. 2023 )
	=	0.173	/	0.575
	=	0.30

Ono Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	0.175
	=	0.00

Ono Pharmaceutical Co (OTCPK:OPHLY) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Ono Pharmaceutical Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLY) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

OPHLF:USA 4528:Japan ON4:Germany

Address

8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564

Website

http://www.ono.co.jp

Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Headlines

From GuruFocus

T. Rowe Price Japan Fund Purchases 5 Stocks in 3rd Quarter

By Holly LaFon Holly LaFon • 10-18-2017

Ono Pharmaceutical Co Stock Appears To Be Modestly Undervalued

By GF Value • 07-05-2021

Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million

By PRNewswire • 12-01-2023

Samuel Isaly's Eaton Vance Worldwide Health Sciences Fund Q1 Investment Report

By Holly LaFon Holly LaFon • 05-13-2016